<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2021</study_start_year><data_sharing_plan>IPD Sharing (as of November 2021): Yes
Description: Anonymized IPD that underlie the results in a publication are planned to be made available upon request of scientists.
Time frame: 6 months after date of publication until 60 months after date of publication
Access Criteria: Data will be made available to other scientists upon request for nonprofit research. The contact address is monika.klinkhammer-schalke@ur.de. Scientists are required to send their predefined statistical analysis plan. Together with the scientific review board of the Tumor Center Regensburg a decision will be made based on the quality and usefulness of planned statistical analysis. In case of a positive decision the scientist is required to sign a contract for data usage before receiving anonymized IPD.</data_sharing_plan><condition>Colorectal Cancer</condition><condition>Colorectal Neoplasms</condition><condition>Survivorship</condition><disease>Colorectal Cancer</disease><disease>Colorectal Neoplasms</disease><disease>Survivorship</disease><study_type>Observational</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2380850</full_dataset_link><location>Germany</location><study_start_month>4</study_start_month><keyword>Complex intervention</keyword><keyword>Health services research</keyword><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>Quality of Life and Survival of Patients With Colorectal Cancer 5 Years After Surgery - Follow-up of the RCT DIQOL</name><description>This observational follow-up study of the randomized trial (RCT) DIQOL investigates long-term effects of an intervention with quality of life (QoL) diagnosis and therapy on present QoL, survival, and recurrence-free survival of colorectal cancer survivors more than 5 years after surgery.
Moreover, patients’ experiences with aftercare for colorectal cancer during the COVID-19 pandemic and their recollections of their illness and therapy are examined.</description><dates><creation>2021-04-15</creation></dates><accession>2380850</accession><cross_references><ClinicalTrials___gov>NCT04930016</ClinicalTrials___gov></cross_references></HashMap>